Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-589-1 | CAS number: 97-53-0
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
A computational network model that integrates 18 in vitro, high-throughput screening assays measuring estrogen receptor (ER) binding, dimerization, chromatin binding, transcriptional activation, and ER-dependent cell proliferation. The network model uses activity patterns across the in vitro assays to predict whether a chemical is an ER agonist or antagonist, or is otherwise influencing the assays through a manner dependent on the physics and chemistry of the technology platform (“assay interference”).
The chemical structure of eugenol was investigated in the Derek Nexus (Q)SAR system for potential structural alerts for oestrogenicity and thyroid toxicity. In both cases the prediction was negative and it is concluded that eugenol does not have a potential for endocrine disruption.
A validated (standardized) estrogen receptor (ER) competitive-binding assay was used to determine the ER affinity for Eugenol. Uteri from ovariectomized Sprague-Dawley rats were the ER source for the competitive-binding assay. Eugenol was demonstrated to have no binding affinity for the estrogen receptor.
A two-generation reproductive toxicity study on a read-across substance (isoeugenol) showed no effects on any other reproductive parameters throughout both generations. Sperm parameters and vaginal cytology were unchanged in the F0 and F1 generations.
Additional information
A computational network model that integrates 18 in vitro, high-throughput screening assays measuring estrogen receptor (ER) binding, dimerization, chromatin binding, transcriptional activation, and ER-dependent cell proliferation. The network model uses activity patterns across the in vitro assays to predict whether a chemical is an ER agonist or antagonist, or is otherwise influencing the assays through a manner dependent on the physics and chemistry of the technology platform (“assay interference”).
Eugenol is predicted negative for estrogen endocrine disruptor potential in a battery of 18 in vitro high-throughput assays. Isoeugenol and methyleugenol are also predicted to have no estrogen endocrine disruptor potential.
The chemical structure of eugenol was investigated in the Derek Nexus (Q)SAR system for potential structural alerts for oestrogenicity and thyroid toxicity. In both cases the prediction was negative and it is concluded that eugenol does not have a potential for endocrine disruption.
A validated (standardized) estrogen receptor(ER) competitive-binding assay was used to determine the ER affinity for Eugenol. Uteri from ovariectomized Sprague-Dawley rats were the ER source for the competitive-binding assay. Eugenol was demonstrated to have no binding affinity for the estrogen receptor.
A two-generation reproductive toxicity study on a read-across substance (isoeugenol) showed no effects on any other reproductive parameters throughout both generations. Sperm parameters and vaginal cytology were unchanged in the F0 and F1 generations.
Based on good quality high-throughput data, a (Q)SAR prediction and a validated in vitro estrogen receptor binding assay generated on the substance itself, and on good quality in vivo data generated on a close structural analogue, it is concluded that eugenol has no potential for endocrine disruptor activity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
